Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
editorial
. 1998 Aug;42(8):2151. doi: 10.1128/aac.42.8.2151

Possible Link between Bacterial Resistance and Use of Antibiotics and Biocides

A D Russell 1, Unchalee Tattawasart 1, J-Y Maillard 1, J R Furr 1
PMCID: PMC105894  PMID: 9722471

Low-level plasmid-mediated resistance to cationic biocides such as chlorhexidine (CHX), quaternary ammonium compounds (QACs), amidines, and acridines has been observed in antibiotic-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis (1, 4, 5), and it has been postulated that strains in which qac genes are present might have enhanced survival in the clinical environment. Extensive use of cationic biocides could lead to the selection of staphylococcal strains showing resistance to both antibiotics and biocides (9, 11), but the clinical relevance of this possibility remains contentious (8).

Although plasmid-mediated resistance to biocides has also been found in gram-negative bacteria, it has been proposed (8) that intrinsic resistance in these organisms is of greater significance. Resistance to both antibiotics and biocides in gram-negative organisms is more likely where less specific mechanisms are involved, e.g., the outer membrane may act as a nonspecific exclusion blanket thereby preventing the uptake of chemically unrelated molecules (10, 11). There have, however, been some instances where biocides have been claimed to select for resistant gram-negative bacteria. Stickler et al. (12) observed resistance to CHX, QACs and at least five antibiotics for gram-negative bacteria isolated from urinary tract infections and proposed that the widespread use of CHX was responsible for selecting antibiotic-resistant strains. There was no evidence of plasmid-linked resistance association (although the possibility was raised but not proven that CHX-resistant strains were acting as more efficient recipients of plasmids conferring antibiotic resistance). Dance et al. (2) isolated a strain of Proteus mirabilis, responsible for a hospital outbreak, that was resistant to CHX and antibiotics. However, there was no evidence of a genetic linkage between these resistances, which were considered to be intrinsic rather than plasmid mediated. Selection of antibiotic-resistant bacteria by chlorination of drinking water and treated sewage has also been described, and the basis of linked biocide-antibiotic resistance in organisms isolated from aquatic sources is of potential public health importance (9).

We have developed stable CHX resistance in some strains of Pseudomonas stutzeri by exposure to increasing concentrations of the bisbiguanide. MICs of CHX for parent strains were 2.5 to 5 μg/ml and MICs for resistant strains were 10 to 100 μg/ml. The CHX-resistant strains showed a variable increase in resistance to QACs (benzalkonium chloride and cetylpyridinium chloride) and to triclosan (increases in MICs of the phenolic of 25- to 250-fold). Additionally, these CHX-resistant strains also demonstrated a variable increase in resistance to polymyxin B, gentamicin, nalidixic acid, erythromycin, and ampicillin (Table 1). Resistant cells took up less CHX from solution than susceptible cells and cell envelope changes were observed microscopically, implicating the outer membrane as being involved in this reduced susceptibility.

TABLE 1.

Responses of CHX-susceptible and CHX-resistant strains of P. stutzeri to other antibacterial agents

Antibacterial agenta MIC (μg/ml) for P. stutzerib
568 568R 10783 10783R JM 302 JM 302R
CHX 2.5 10 2.5 50 2.5 100
CPC 25 100 25 250 50 100
TC 1 250 1 1 1 25
PB <1 >500 <1 <1 <1 200
GM 2.5 5 <1 <1 <1 100
NA 5 100 25 25 10 10
EM 25 >200 25 >200 50 5
AM 10 >500 100 100 50 300
a

CPC, cetylpyridinium chloride; TC, triclosan; PB, polymyxin B sulfate; GM, gentamicin; NA, nalidixic acid; EM, erythromycin; AM, ampicillin. 

b

R denotes CHX-resistant strain. 

Moken et al. (6) have described the selection of low-level chromosomal antibiotic resistance in Escherichia coli following exposure to a sublethal concentration of pine oil and have demonstrated that an export resistance mechanism (3) was involved. They also found that deletion of acrAB, but not of mar, resulted in a >10-fold increase in susceptibility of strains to a QAC and to chloroxylenol and thereby surmised that acrAB was also involved in efflux of these two biocides.

Concern about a possible linkage between antibiotic and biocide resistance has again been expressed recently (7) and clearly needs to be considered further in a clinical context. It is likely that more than one type of mechanism, viz., outer membrane changes and efflux, is involved.

REFERENCES

  • 1.Behr H, Reverdy M E, Mabilat C, Freney J, Fleurette J. Relation entre le niveau des concentrations minimales inhibitrices de cinq antiseptiques et la présence du gène qacA chez Staphylococcus aureus. Pathol Biol. 1994;42:438–444. [PubMed] [Google Scholar]
  • 2.Dance D A B, Pearson A D, Seal D V, Lowes J A. A hospital outbreak caused by a chlorhexidine and antibiotic resistant Proteus mirabilis. J Hosp Infect. 1987;10:10–16. doi: 10.1016/0195-6701(87)90027-2. [DOI] [PubMed] [Google Scholar]
  • 3.George A M. Multidrug resistance in enteric and other Gram-negative bacteria. FEMS Microbiol Lett. 1996;139:1–10. doi: 10.1111/j.1574-6968.1996.tb08172.x. [DOI] [PubMed] [Google Scholar]
  • 4.Leelaporn A, Paulsen I T, Tennent J M, Littlejohn T G, Skurray R A. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J Med Microbiol. 1994;40:214–220. doi: 10.1099/00222615-40-3-214. [DOI] [PubMed] [Google Scholar]
  • 5.Lyon B R, Skurray R A. Antimicrobial resistance of Staphyloccus aureus: genetic basis. Microbiol Rev. 1987;51:88–134. doi: 10.1128/mr.51.1.88-134.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moken M C, McMurry L M, Levy S B. Selection of multiple antibiotic-resistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and AcrAB loci. Antimicrob Agents Chemother. 1997;41:2770–2772. doi: 10.1128/aac.41.12.2770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Royal Pharmaceutical Society of Great Britain. Resistance to antimicrobial agents: submission to House of Lords subcommittee. Pharm J. 1997;259:919–921. [Google Scholar]
  • 8.Russell A D. Plasmids and bacterial resistance to biocides. J Appl Microbiol. 1997;82:155–165. doi: 10.1046/j.1365-2672.1997.00198.x. [DOI] [PubMed] [Google Scholar]
  • 9.Russell A D, Chopra I. Understanding antibacterial action and resistance. 1996. pp. 226–237. , 266–269. Ellis Horwood, Chichester, United Kingdom. [Google Scholar]
  • 10.Russell A D, Furr J R, Maillard J-Y. Microbial susceptibility and resistance to biocides. ASM News. 1997;63:481–487. [Google Scholar]
  • 11.Russell A D, Russell N J. Biocides: activity, action and resistance. In: Hunter P A, Darby G K, Russell N J, editors. Fifty years of antimicrobials: past perspectives and future trends. 53rd Symposium of the Society for General Microbiology. Cambridge, United Kingdom: Cambridge University Press; 1995. pp. 327–365. [Google Scholar]
  • 12.Stickler, D. J., B. Thomas, J. C. Clayton, and J. A. Chawla. 1983. Studies on the genetic basis of chlorhexidine resistance. Brit. J. Clin. Prac. Symp. 25(Suppl.):23–28.

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES